Market access for a medical device in Russia or the EAEU starts with the product itself. Confirm its intended medical purpose, decide whether it is a medical device, accessory or software, then identify the relevant registration route. Only after that should you separate registration from EAC and other operational checks.
The practical decision path is straightforward. First, describe what the product does and why it is used. Next, review its regulatory identity and classification questions. Then define the dossier and the applicant role. Finally, establish whether the project concerns medical device registration in Russia, EAEU registration, or both, and check any separate operational requirements.
What does market access cover?
Market access is the process of determining what must be established before a medical device can be placed on the relevant market. For Russia and the EAEU, the starting point is not the product name or a commercial description. It is the intended medical purpose and the way the product is presented and used.
The scope may include the product’s regulatory status, classification questions, the registration route, the registration dossier and the applicant. It may also include a review of whether the item is a device, an accessory or software. These decisions affect how the project should be organised and what information must be assembled.
Market access does not mean that every product follows one identical route. A physical device, an accessory and software may raise different questions. A product sold as part of a system may also need to be considered separately from the system itself. The correct starting point is therefore a product-specific assessment.
Does the product need medical device registration?
The answer depends on the intended medical purpose and the product’s regulatory identity. A product should not be treated as a medical device solely because it is used in a healthcare setting. Conversely, software or an accessory should not be excluded from review merely because it is not the main physical device.
Prepare a clear description of the product’s intended use. Explain what it is designed to do, who uses it and how it supports the medical purpose. Include the product name, model or range information available to you, and a description of any software or accessories supplied with it.
This information supports the first decision. It helps distinguish a medical device from an accessory or software and identifies the classification questions that require further review. It also prevents the registration route from being selected on the basis of an incomplete commercial description.
Which product questions should be answered first?
Begin with the following product inputs.
- What is the intended medical purpose?
- What function does the product perform?
- Is the product a medical device, an accessory, software, or a combination of these?
- Is the product supplied alone or as part of a wider system?
- Which models, variants or product families are within the proposed scope?
- What information is already available for the dossier?
- Who is expected to act as the applicant?
- Is the target market Russia, the EAEU, or a route that must be considered across both?
These questions do not assign a risk class to a hypothetical product. They establish the information needed to examine classification and route decisions without making assumptions that the available facts do not support.
How are devices, accessories and software treated?
The distinction between a medical device, an accessory and software is a central part of the assessment. The label used by the manufacturer is not enough on its own. The intended purpose and the function supplied to the user must be considered together.
A medical device is assessed as the product that performs the stated medical function. An accessory may support the use of a device without being the main device itself. Software may be supplied separately or as part of a product. Each possibility should be described clearly so that the scope of the project is not wider or narrower than the actual product.
When a product includes software, identify the software’s role. State whether it operates the device, supports a medical function or is supplied as a separate element. When accessories are included, list them and explain how they relate to the main product. This creates a usable basis for classification questions and dossier planning.
What is the difference between registration and EAC?
Medical device registration is not the same as EAC. They are separate questions and should not be treated as interchangeable approvals.
Registration concerns the medical device route and the information required for that route. EAC concerns a separate conformity question. Other operational checks may also need to be considered. The presence of an EAC question does not remove the need to examine medical device registration, and a registration assessment does not by itself answer every operational question.
Keep these workstreams separate in the project plan. First confirm the product’s medical device status and registration route. Then identify whether EAC or other operational checks apply to the product and its intended use. The required checks should be based on the actual product scope, not on a general assumption about medical equipment.
Should the supplier choose a Russian or EAEU route?
The route should be selected after the product and market scope have been reviewed. A supplier needs to state whether it is preparing for Russia, the EAEU, or a wider commercial plan involving both. That decision affects how the project is defined and which registration questions must be addressed.
Do not select a route only because the product is manufactured outside the EAEU. The relevant factors include the intended medical purpose, product identity, classification questions, dossier position and applicant role. The commercial destination must then be matched with the appropriate registration assessment.
For a project focused on Russia, the scope should identify Russia as the target market and examine the applicable medical device registration position. For an EAEU project, the scope should identify the EAEU objective and examine the EAEU registration position. If both markets matter, record both objectives at the outset rather than leaving the distinction until the dossier is prepared.
What should be prepared before the assessment?
A supplier should prepare a concise product pack. It does not need to answer every regulatory question in advance. It should give enough information to identify the product, its purpose and the proposed market scope.
- A description of the intended medical purpose.
- A practical explanation of how the product works and how it is used.
- The product name, models and variants within the proposed scope.
- A list of accessories supplied with the product.
- A description of any software and its role in the product.
- Available technical and product information for the dossier.
- The supplier’s proposed applicant arrangement.
- The intended market, whether Russia, the EAEU, or both.
- Any existing view on registration, EAC or other operational checks.
Use consistent wording across the product description and supporting information. If the intended purpose changes between documents, the classification and route assessment may also change. Where information is not yet available, identify the gap rather than filling it with an assumption.
What is the registration dossier?
The dossier is the organised body of information used for the medical device registration route. Its scope depends on the product and the route under review. It should therefore be planned after the intended purpose, product identity and market objective have been defined.
Dossier planning should address what information exists, what information needs clarification and who is responsible for each part. The supplier should identify the documents held by the manufacturer and any information held by other parties. The project should also record who will act as the applicant.
A dossier review is not a substitute for deciding whether the product is a device, accessory or software. Those questions come first because they determine what the dossier is intended to support. Likewise, dossier planning does not answer EAC or other operational checks unless those checks are examined separately.
Who does what in the project?
The manufacturer or supplier provides the product facts. This includes the intended medical purpose, product description, models, accessories, software information and available dossier material. The supplier also states the commercial objective and its preferred applicant arrangement.
The applicant has a defined role in the registration project. That role should be identified early and recorded against the proposed route. If the applicant position is unclear, the project should not treat the dossier as complete.
The regulatory work focuses on organising the decision path. It examines the product identity, classification questions, registration scope, dossier position and applicant role. It also keeps medical device registration distinct from EAC and other operational checks.
These responsibilities should be agreed before documents are assembled in detail. A supplier may hold the technical information while another party is expected to act as applicant. Recording that division prevents missing information and avoids confusion over who must provide or confirm each item.
What decisions are made during the workflow?
- Define the product. Record the intended medical purpose, main function, models, accessories and software.
- Confirm the regulatory identity. Decide whether the proposed scope concerns a medical device, an accessory, software or more than one product element.
- Review classification questions. Examine the information needed to determine the relevant classification position without assigning a class before the product facts support it.
- Set the market scope. State whether the objective concerns Russia, the EAEU, or both.
- Plan the dossier. List the information available, identify gaps and allocate responsibility for the required material.
- Define the applicant role. Confirm who will act as applicant for the proposed registration work.
- Separate other checks. Review EAC and other operational questions as distinct workstreams.
- Choose the service scope. Confirm whether the requirement is an initial assessment, dossier and applicant planning, or the wider commercial registration process.
This sequence keeps the project anchored to the actual product. It also makes clear which questions can be answered from the supplier’s information and which require further assessment.
What does the registration service deliver?
The separate medical device registration service is the commercial route for organising registration work. Its scope should reflect the product inputs and decisions above. The service can be defined around the intended purpose, product identity, classification questions, dossier position, applicant role and target market.
The service scope should also state what it does not combine automatically. EAC and other operational checks remain separate unless they are expressly included in the agreed work. A supplier should therefore describe the required outcome precisely when requesting a quotation.
For a clear request, state the product type, intended medical purpose, models or range, software and accessories, target market, available dossier information and proposed applicant. Then identify whether the request concerns Russia, the EAEU or both. This gives the registration work a defined boundary.
How is the quotation scope determined?
A quotation is shaped by the information and decisions required for the particular product. The relevant factors include the intended medical purpose, the number and relationship of models, whether software or accessories are included, the classification questions, the proposed market, the dossier position and the applicant arrangement.
Quotation scope also depends on whether the supplier needs a focused review or the wider commercial registration process. A project that requires only route clarification is different from one that requires the registration scope, dossier planning and applicant role to be organised together.
State separately whether EAC or other operational checks are required. This avoids treating those checks as part of medical device registration by default. It also allows the work to be described against the actual product rather than against a general category of medical equipment.
Example decision for a supplier
Consider a supplier with a product that includes a main device, an accessory and software. The supplier wants to sell in Russia and may also pursue the EAEU market. It should not request a quotation using only the product’s commercial name.
The supplier should first describe the intended medical purpose and explain the function of the main device. It should then list the accessory and state how it supports the device. The software should be described separately, including its role in the product. The supplier should identify the models in scope and state whether the commercial objective covers Russia, the EAEU or both.
Next, the supplier should provide the dossier information already available and identify the proposed applicant. The registration assessment can then focus on the correct product scope, classification questions, dossier position and route. EAC and other operational checks should be listed as separate questions.
This example leads to a practical decision. If the supplier has not yet decided whether the EAEU objective is part of the initial project, it should not describe the request as a single undifferentiated market-access task. It should state the Russia objective, the possible EAEU objective and the decision still required.
What should the supplier avoid?
- Do not rely on a product name without describing its intended medical purpose.
- Do not assume that every healthcare product is a medical device.
- Do not treat software or accessories as irrelevant to the product scope.
- Do not assign a classification position before the product facts have been reviewed.
- Do not combine medical device registration with EAC as though they were the same process.
- Do not leave the applicant role undefined while preparing the dossier.
- Do not describe Russia and the EAEU as one market objective without stating the intended route.
- Do not request a quotation without identifying the product elements and available information.
Frequently asked questions
Is EAC enough to place a medical device on the market?
No. EAC and medical device registration are separate questions. The product’s medical device status and registration route must be assessed separately from EAC and other operational checks.
Can software or an accessory be ignored in the registration assessment?
No. Software and accessories form part of the product-scope review. The supplier should describe their function and relationship with the main product so that the relevant classification and dossier questions can be considered.
Can the correct route be chosen without stating the intended medical purpose?
The intended medical purpose is a starting input for the assessment. Without it, the product’s regulatory identity and classification questions cannot be considered on a properly defined basis.
What information should be included in a request for the registration service?
Include the intended medical purpose, product function, models, accessories, software, available dossier information, proposed applicant and target market. State whether the objective concerns Russia, the EAEU or both, and list EAC or other operational checks separately.
A well-defined product scope gives the supplier a clearer route through medical device registration in Russia and the EAEU.
Choose between a Russian and an EAEU filing
The EAEU transition permits eligible examination or registration applications under national rules through 31 December 2027. The common EAEU route is also available. Check the filing date, intended markets and territory of circulation before deciding which dossier to prepare. For the Russian national route, check the current instructions from Roszdravnadzor.
Compare the certificate and declaration routes and check what evidence applies to your product.